Page last updated: 2024-10-21

1,3-dipropyl-8-cyclopentylxanthine and Nasopharyngeal Carcinoma

1,3-dipropyl-8-cyclopentylxanthine has been researched along with Nasopharyngeal Carcinoma in 1 studies

DPCPX : An oxopurine that is 7H-xanthine substituted at positions 1 and 3 by propyl groups and at position 8 by a cyclohexyl group.

Nasopharyngeal Carcinoma: A carcinoma that originates in the EPITHELIUM of the NASOPHARYNX and includes four subtypes: keratinizing squamous cell, non-keratinizing, basaloid squamous cell, and PAPILLARY ADENOCARCINOMA. It is most prevalent in Southeast Asian populations and is associated with EPSTEIN-BARR VIRUS INFECTIONS. Somatic mutations associated with this cancer have been identified in NPCR, BAP1, UBAP1, ERBB2, ERBB3, MLL2, PIK3CA, KRAS, NRAS, and ARID1A genes.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Pan, S1
Zhang, X1
Guo, Y1
Li, Y1

Other Studies

1 other study available for 1,3-dipropyl-8-cyclopentylxanthine and Nasopharyngeal Carcinoma

ArticleYear
DPCPX induces Bim-dependent apoptosis in nasopharyngeal carcinoma cells.
    Cell biology international, 2022, Volume: 46, Issue:12

    Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Humans; Mice; Mice, Nude; Nasopharyngeal C

2022